Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association

International Journal of Cancer

Volumn 130, Issue 6, 2012, Pages 1273-1283

  Fecchi, Katia ^a   Travaglione, Sara ^a   Spadaro, Francesca ^a   Quattrini, Adriano ^a   Parolini, Isabella ^a   Piccaro, Giovanni ^a   Raggi, Carla ^a   Fabbri, Alessia ^a   Felicetti, Federica ^a   Carè, Alessandra ^a   Fiorentini, Carla ^a   Sargiacomo, Massimo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

caveolin 1; FGFR; melanoma; Rho GTPases; Src

Indexed keywords

CAVEOLIN 1; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RHO FACTOR;

ARTICLE; CAVEOLA; CELL ANCHORAGE; CELL DENSITY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUCROSE GRADIENT;

ACTINS; CAVEOLIN 1; CELL COUNT; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CYTOSKELETON; HUMANS; MAP KINASE SIGNALING SYSTEM; MELANOMA; PHOSPHORYLATION; RECEPTORS, FIBROBLAST GROWTH FACTOR; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84856102082     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26092     Document Type: Article

References (49)

1. Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn M,. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 1999; 18: 6469-76.
2. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004; 64: 5270-82. (Pubitemid 39006547)
3. Care A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, Peschle C, Colombo MP,. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 1996; 16: 4842-51. (Pubitemid 26272139)
4. Care A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP,. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res 2001; 61: 6532-9. (Pubitemid 32783261)
5. Sandilands E, Frame MC,. Endosomal trafficking of src tyrosine kinase. Trends Cell Biol 2008; 18: 322-9.
6. Sandilands E, Akbarzadeh S, Vecchione A, McEwan DG, Frame MC, Heath JK,. Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors. EMBO Rep 2007; 8: 1162-9. (Pubitemid 350201735)
7. Glenney JR, Jr,. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by rous sarcoma virus. J Biol Chem 1989; 264: 20163-6. (Pubitemid 20009187)
8. del Pozo MA, Balasubramanian N, Alderson NB, Kiosses WB, Grande-Garcia A, Anderson RG, Schwartz MA,. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol 2005; 7: 901-8. (Pubitemid 41486291)
9. Wary KK, Mariotti A, Zurzolo C, Giancotti FG,. A requirement for caveolin-1 and associated kinase fyn in integrin signaling and anchorage-dependent cell growth. Cell 1998; 94: 625-34. (Pubitemid 28427581)
10. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA,. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 1999; 144: 1285-94. (Pubitemid 29157305)
11. Stahlhut M, van Deurs B,. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell 2000; 11: 325-37. (Pubitemid 30075526)
12. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA,. Caveolin-1 regulates cell polarization and directional migration through src kinase and Rho GTPases. J Cell Biol 2007; 177: 683-94. (Pubitemid 46799839)
13. Williams TM, Lisanti MP,. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288: C494-506. (Pubitemid 40229478)
14. Goetz JG, Lajoie P, Wiseman SM, Nabi IR,. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 2008; 27: 715-35.
15. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC,. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 1998; 4: 1873-80. (Pubitemid 28369170)
16. Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC,. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res 2003; 9: 3653-9. (Pubitemid 37169231)
17. Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI, Shariat SF,. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 2007; 67: 614-22. (Pubitemid 46685281)
18. Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ,. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 2004; 93: 291-6. (Pubitemid 38253572)
19. Felicetti F, Parolini I, Bottero L, Fecchi K, Errico MC, Raggi C, Biffoni M, Spadaro F, Lisanti MP, Sargiacomo M, Care A,. Caveolin-1 tumor-promoting role in human melanoma. Int J Cancer 2009; 125: 1514-22.
20. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Care A,. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745-54. (Pubitemid 351556272)
21. van Deurs B, von Bulow F, Vilhardt F, Holm PK, Sandvig K,. Destabilization of plasma membrane structure by prevention of actin polymerization. microtubule-dependent tubulation of the plasma membrane. J Cell Sci 1996; 109: 1655-65. (Pubitemid 26248611)
22. Lisanti MP, Tang ZL, Sargiacomo M,. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol 1993; 123: 595-604. (Pubitemid 23324917)
23. Fecchi K, Volonte D, Hezel MP, Schmeck K, Galbiati F,. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 2006; 20: 705-7. (Pubitemid 46671188)
24. Travaglione S, Messina G, Fabbri A, Falzano L, Giammarioli AM, Grossi M, Rufini S, Fiorentini C,. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of rho GTPases. Cell Death Differ 2005; 12: 78-86. (Pubitemid 40090030)
25. Lisanti MP, Tang Z, Scherer PE, Sargiacomo M,. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol 1995; 250: 655-68.
26. Biedi C, Panetta D, Segat D, Cordera R, Maggi D,. Specificity of insulin-like growth factor I and insulin on shc phosphorylation and Grb2 recruitment in caveolae. Endocrinology 2003; 144: 5497-503. (Pubitemid 37476079)
27. Kanai M, Goke M, Tsunekawa S, Podolsky DK,. Signal transduction pathway of human fibroblast growth factor receptor 3. identification of a novel 66-kDa phosphoprotein. J Biol Chem 1997; 272: 6621-8. (Pubitemid 27118147)
28. Cerezo A, Guadamillas MC, Goetz JG, Sanchez-Perales S, Klein E, Assoian RK, del Pozo MA,. The absence of caveolin-1 increases proliferation and anchorage- independent growth by a rac-dependent, erk-independent mechanism. Mol Cell Biol 2009; 29: 5046-59.
29. Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE,. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene 2005; 24: 3459-71. (Pubitemid 40756247)
30. Li S, Couet J, Lisanti MP,. Src tyrosine kinases, galpha subunits, and H-ras share a common membrane-anchored scaffolding protein, caveolin. caveolin binding negatively regulates the auto-activation of src tyrosine kinases. J Biol Chem 1996; 271: 29182-90. (Pubitemid 26382628)
31. Cao H, Sanguinetti AR, Mastick CC,. Oxidative stress activates both src-kinases and their negative regulator csk and induces phosphorylation of two targeting proteins for csk: caveolin-1 and paxillin. Exp Cell Res 2004; 294: 159-71. (Pubitemid 38229790)
32. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP,. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998; 17: 6633-48. (Pubitemid 28521797)
33. Del Pozo MA, Schwartz MA,. Rac, membrane heterogeneity, caveolin and regulation of growth by integrins. Trends Cell Biol 2007; 17: 246-50. (Pubitemid 46679242)
34. Echarri A, Muriel O, Del Pozo MA,. Intracellular trafficking of raft/caveolae domains: Insights from integrin signaling. Semin. Cell Dev Biol 2007; 18: 627-37. (Pubitemid 350026428)
35. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A,. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J Cell Biol 2010; 191: 615-29.
36. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA,. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006; 281: 26391-9. (Pubitemid 44401847)
37. Pelkmans L, Helenius A,. Endocytosis via caveolae. Traffic 2002; 3: 311-20. (Pubitemid 34461041)
38. Botos E, Turi A, Mullner N, Kovalszky I, Tatrai P, Kiss AL,. Regulatory role of kinases and phosphatases on the internalisation of caveolae in HepG2 cells. Micron 2007; 3: 313-20. (Pubitemid 46027593)
39. Etienne-Manneville S, Hall A,. Rho GTPases in cell biology. Nature 2002; 420: 629-35. (Pubitemid 36764489)
40. Huveneers S, Danen EH,. Adhesion signaling-crosstalk between integrins, src and rho. J Cell Sci 2009; 122: 1059-69.
41. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M,. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994; 126: 111-26. (Pubitemid 24214933)
42. Parton RG,. Caveolae and caveolins. Curr Opin Cell Biol 1996; 8: 542-8. (Pubitemid 26254052)
43. Couet J, Sargiacomo M, Lisanti MP,. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 1997; 272: 30429-38. (Pubitemid 27512253)
44. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC, Lisanti MP,. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A 1995; 92: 9407-11.
45. Parton RG, Simons K,. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185-94.
46. Thompson TC,. Metastasis-related genes in prostate cancer: the role of caveolin-1. Cancer Metastasis Rev 1998-1999; 17: 439-42.
47. Mammoto A, Huang S, Ingber DE,. Filamin links cell shape and cytoskeletal structure to rho regulation by controlling accumulation of p190RhoGAP in lipid rafts. J Cell Sci 2007; 120: 456-67. (Pubitemid 46332509)
48. Goetz JG, Joshi B, Lajoie P, Strugnell SS, Scudamore T, Kojic LD, Nabi IR,. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 2008; 180: 1261-75. (Pubitemid 351468479)
49. Swaney JS, Patel HH, Yokoyama U, Head BP, Roth DM, Insel PA,. Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J Biol Chem 2006; 281: 17173-9.